JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B4756 YH239-EE

Summary: p53-MDM2 antagonist, potent

≥50.4 mg/mL
B3553 GS-9973

Target: Syk

Summary: Syk inhibitor, orally bioavailable and selective

insoluble in EtOH; insoluble in H2O; ≥20.55 mg/mL
B4764 TCS-PIM-1-4a

Summary: Pim inhibitor
B4840 ZLN024 hydrochloride

Summary: novel AMPK allosteric activator

≥33.2 mg/mL
B4862 CWHM-12

Summary: inhibitor of αV integrins

≥10.6 mg/mL
B8031 MK-571 sodium salt hydrate
3 Citation

Target: CysLT1

Summary: CysLT1 receptor antagonist

≥10.3 mg/mL
A8694 AI-10-49

Summary: A selective leukemia oncoprotein CBFβ-SMHHC inhibitor

≥16.53 mg/mL
B4894 SP2509

Target: Histone Demethylases

Summary: Demethylase 1 (LSD1) antagonist, novel Lysine-specific

insoluble in H2O; insoluble in EtOH; ≥19.45 mg/mL
B4913 Corylifol A

Summary: STAT3 inhibitor

Soluble in DMSO
B5952 LFM-A13

Summary: BTK-specific tyrosine kinase inhibitor

≥36 mg/mL